Medical Marijuana Market to Experience Blatant Growth at 35.4% of CAGR during the Forecast Period 2019-2023

According to Market Research Future, the Global Medical Marijuana Market to provide readers with a clear view of the market’s likely growth trajectory over the coming years. The report utilizes historical trends of the Global Medical Marijuana Market and present statistics to derive.

Pune, India - February 12, 2019 /MarketersMedia/ —

Medical Marijuana Market - Synopsis

Global Medical Marijuana Market is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023. Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions.

Marijuana consists of chemical components cannabinoids,  which can be used as medicine to treat the symptoms caused by illness. Medical marijuana plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising acceptance of medical marijuana in healthcare and increasing research and development activities are the major factors driving the growth of the global medical marijuana market. Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market. For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6470

The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.

Top Players:

The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.

Segmentation:

The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.

On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS). Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).

The route of administration segment has been further divided into oral, topical, inhalation and sublingual. The topical segment has been classified into ointments, lotions, creams, gels, and poultice.

The market, by distribution channel, has been segmented into dispensaries and online platforms.

Industry Updates:

In January 2019, it has been announced by the Arkansans Department of Health that the patients who are approved for purchasing medical; marijuana will receive patient cards by February 2019.

In January 2019, it has been announced that within next few days residents in Ohio will be able to purchase marijuana for medical purposes.

In January 2019, Trulieve, Florida's largest and first medical marijuana provider, has signed a deal to bring high-end edible marijuana products to Florida and will soon be made available for the registered medical marijuana patients in the form of cannabis chocolates, granola bars, honey, fruit leather, olive oil and more.

Medical Marijuana Market - Regional Analysis:

The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies.

Browse Complete 85 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Some Points From TOC of Medical Marijuana Market Research Report – Forecast to 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC CONTINUED…!

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Source URL: https://marketersmedia.com/medical-marijuana-market-to-experience-blatant-growth-at-354-of-cagr-during-the-forecast-period-2019-2023/481621

Source: MarketersMedia

Release ID: 481621

More News From Business - Malaysian Talks

China bars millions from travel for 'social credit' offenses

Feb 22, 2019

BEIJING — Forgot to pay a fine in China? Then forget about buying an airline ticket. Would-be air travelers were blocked from buying tickets 17.5 million times last year under a controversial "social credit" system the ruling Communist Party says will improve public behavior. Some 5.5 million people were barred from buying train tickets, according to the National Public Credit Information Center. In an annual report, it said 128 people were blocked from leaving China because they were behind on their taxes. The ruling party says penalties and rewards under "social credit" will improve order in a fast-changing society. Three...

China's new policy against gender bias meets fans, sceptics

Feb 22, 2019

BEIJING — China has announced new measures against gender discrimination in Chinese workplaces that forbid employers from asking potential female hires questions such as if they are married or have children. At some companies in China, the answers to these questions can be disqualifying. Other firms are explicit in their job postings that they are looking only for men. Many welcomed the government notice, published Thursday, which forbids companies and recruitment agencies from taking certain discriminatory actions against female employees and job candidates. But female workers and analysts alike were skeptical that such measures could be strictly enforced. "A notice...

Global shares mixed as investors watch trade talks

Feb 22, 2019

TOKYO — Global shares were mixed Friday as nervous investors await developments in the U.S.-China trade talks in Washington. European shares rose, with France's CAC 40 gaining 0.3 percent in midday trading to 5,212. Germany's DAX was up 0.6 percent at 11,487 and Britain's FTSE 100 rose 0.5 percent to 7,204. U.S. shares were set to open higher as Dow futures rose 0.5 percent to 25,970. S&P 500 futures also rose close to 0.5 percent, to 2,786. A hodge-podge of recent economic data is fueling concerns over risks to global growth and the world's two biggest economies are locked in...

Worry about US-SKorea alliance grows before Trump-Kim summit

Feb 22, 2019

SEOUL, South Korea — As President Donald Trump seeks a nuclear deal with North Korean leader Kim Jong Un next week in Vietnam, some in Seoul are wondering if the fate of Washington's decades-long military alliance with South Korea could be at stake. Much of this worry is linked to Trump's repeated assertions that the U.S. military deployment in South Korea is too costly, and to his surprise suspension of some U.S. military exercises with South Korea — including a major summertime drill — as a concession to Kim after their first summit in Singapore last year. Added to this...

Asian shares mostly lower as investors watch trade talks

Feb 22, 2019

TOKYO — Asian shares were mostly lower Friday after a slide on Wall Street as investors nervously watched the U.S.-China trade talks in Washington. Japan's benchmark Nikkei 225 slipped 0.5 percent to 21,368.54 in morning trading. Australia's S&P/ASX 200 gained 0.5 percent to 6,170.30. South Korea's Kospi fell 0.4 percent to 2,220.12. Hong Kong's Hang Seng lost 0.6 percent to 28,446.32, while the Shanghai Composite shed 0.4 percent to 2,742.10. Health care and energy companies led U.S. stocks lower. The S&P 500, which has risen for the past three weeks, fell 9.82 points, or 0.4 percent, to 2,774.88. The Dow...